FIELD: chemistry.
SUBSTANCE: invention relates to derivatives of hambogenic acid corresponding to structural formulae (I) or (II), where A is -CO- or -HC(OH)-; R2 hydrogen or a straight or branched C1-C10 alkyl group; R3 hydrogen or acyl group, substituted with C1-C10 alkyl group; R is hydrogen or a straight or branched C1-C10 alkyl group; R1 is selected from: -OR4, or ; in which R4 is selected from a group consisting of any of the following: hydrogen, straight or branched C1-C10 alkyl group or an alkyl group, possibly containing from 1 to 3 substituted groups, including oxygen, C1-C10 alkoxy group or with C1-C10 alkoxycarbonyl group; R5 and R6 are independently selected from any of the following substituted groups: hydrogen; straight or branched C1-C10 alkyl group or with C1-C10 alkyl group, possibly containing from 1 to 3 substituted groups, including oxygen, C1-C10 alkoxy group, C1-C10 alkoxyacyl group, C1-C10 alkyl group, substituted with phenyl; s and t are integer positive numbers, and sum of s and t is a natural number from 2 to 4; m is 0, 1, 2 or 3 and represents a number of substituted groups with R7 rings; n is 0, 1, 2 or 3 and represents B on the ring; B is carbon, nitrogen or oxygen; B is carbon, groups R7, R8 are identical to group R5; and R4, R3, R2, R1 and are not simultaneously hydrogen as indicated in Formula (I). Invention also relates to methods of producing compounds of formulae I and II and intermediate compounds and to anticancer pharmaceutical composition based on these compounds.
EFFECT: in comparison with hambogenic acid derivatives hambogenic acid exhibit effective anticancer activity.
13 cl, 5 dwg, 2 tbl, 28 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED CINNAMAMIDE DERIVATIVE, METHOD FOR PRODUCTION AND USE THEREOF | 2012 |
|
RU2587668C2 |
CONDENSED AZA-HETEROCYCLIC AMIDE COMPOUND AND ITS USE | 2021 |
|
RU2811975C1 |
METHOD FOR OBTAINING AZETIDINONE COMPOUNDS AND DERIVATIVES OF AZETIDINONE COMPOUNDS | 2015 |
|
RU2650687C1 |
6-OXO-AZEPINOINDOLE COMPOUNDS AND THEIR PHYSIOLOGICALLY TOLERANTABLE ACID SALTS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS OF THEIR SYNTHESIS | 1992 |
|
RU2078765C1 |
METALLOCENES WITH BENZOFUSED INDENYL DERIVATIVES, METHOD OF THEIR SYNTHESIS, METHOD OF OLEFIN POLYMER PRODUCING AND CATALYST FOR OLEFIN POLYMERIZATION | 1992 |
|
RU2098423C1 |
BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA (RORγ) AND THEIR PHARMACEUTICAL USE | 2019 |
|
RU2789059C2 |
DERIVATIVES OF 1-[2-(SUBSTITUTED VINYL)]-5H-2,3-BENZODIAZEPINE, METHOD OF THEIR SYNTHESIS, INTERMEDIATE COMPOUND, PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING, METHOD OF TREATMENT OF PATIENTS WITH CENTRAL NERVOUS SYSTEM DISEASE | 1996 |
|
RU2161607C2 |
PYRIMIDINE COMPOUND WITH CONDENSED RINGS, ITS INTERMEDIATE COMPOUND, METHOD OF PRODUCING, COMPOSITION AND USE | 2016 |
|
RU2732576C2 |
1-SUBSTITUTED 4-NITROIMIDAZOLE DERIVATIVE AND METHOD OF ITS PRODUCTION | 2003 |
|
RU2324682C2 |
HYDRAZINE DERIVATIVE, INSECTICIDAL COMPOSITION, METHOD OF CONTROLLING PESTS, PROCESS FOR PREPARING HYDRAZINE DERIVATIVE | 1992 |
|
RU2041220C1 |
Authors
Dates
2016-09-20—Published
2012-09-28—Filed